Mortality analysis of Enterococcus faecium bloodstream infection in central Taiwan

被引:2
|
作者
Chen, Chang-Hua [1 ,2 ,4 ]
Lin, Li-Chen [1 ]
Chang, Yu-Jun [3 ]
Chang, Chih-Yen [1 ,2 ]
机构
[1] Hosp Changhua Christian, Comite Control Infecc, Lukang Township, Changhua, Taiwan
[2] Hosp Changhua Christian, Dept Med Interna, Div Enfermedades Infecciosas, Lukang Township, Changhua, Taiwan
[3] Hosp Changhua Christian, Ctr Epidemiol & Estadist, Lukang Township, Changhua, Taiwan
[4] Univ Hung Kuang, Escuela Med & Enfermeria, Dept Enfermeria, Taichung, Taiwan
来源
REVISTA CHILENA DE INFECTOLOGIA | 2016年 / 33卷 / 04期
关键词
Mortality; vancomycin-resistant enterococcus; bloodstream infection; Enterococcus; VANCOMYCIN-RESISTANT ENTEROCOCCI; GRAM-POSITIVE PATHOGENS; ANTIMICROBIAL RESISTANCE; RISK-FACTORS; BACTEREMIA; SURVEILLANCE; FAECALIS; OUTCOMES; PROGRAM; TRENDS;
D O I
10.4067/S0716-10182016000400004
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Bloodstream infections (BSIs) due to Enterococcus faecium (E. faecium), particularly those due to vancomycin-resistant enterococcus (VRE), are still a therapeutic challenge. Aim: To evaluate mortality from BSI due to E. faecium and VRE in central Taiwan. Materials and Methods: We retrospectively analyzed cases of significant E. faecium BSI in the Changhua Christian Hospital System between January 1, 2010 and December 31, 2013. Results: Of the 76 cases, 28 patients (36.8%) were admitted to intensive care units (ICUs) at the onset of BSI, 10 (13.2%) cases were associated with polymicrobial bacteremia, and 29 (38.2%) cases were associated with entry via the biliary tract. VRE was observed in 18 (23.7%) cases. The 30-day mortality rate was 13.1% (10/76). Multivariate logistic regression analysis showed that bacteremia of non-biliary tract origin (OR = 8.43, 95% confidence interval (95% CI) = 1.32-54.00, p = 0.002) and ICU admission (OR = 4.2, 95% CI =1.7-10.0, p = 0.002) were significant risk factors for 30-day mortality, whereas appropriate antimicrobial therapy was a protective factor for 30-day mortality (OR = 0.33, 95% CI = 0.14-0.79, p = 0.013). Conclusions: Our results underscore the need to assist patients admitted to ICUs with E. faecium BSIs with a non-biliary tract origin. We emphasize the use of appropriate antimicrobial therapy for E. faecium BSI with the aim to rescue more patients with these infections.
引用
收藏
页码:395 / 402
页数:8
相关论文
共 50 条
  • [1] Clinical and microbiological characteristics of vancomycin-resistant Enterococcus faecium bloodstream infection in Central Taiwan
    Chen, Chang-Hua
    Lin, Li-Chen
    Chang, Yu-Jun
    Chang, Chih-Yen
    MEDICINE, 2017, 96 (49)
  • [2] Impact of vancomycin resistance in Enterococcus faecium bloodstream infection on mortality: A retrospective analysis of nationwide surveillance data *
    Huh, Kyungmin
    Chung, Doo Ryeon
    Ha, Young Eun
    Ko, Jae-Hoon
    Huh, Hee Jae
    Lee, Nam Yong
    Cho, Sun Young
    Kang, Cheol-In
    Peck, Kyong Ran
    Song, Jae-Hoon
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 134 : 8 - 14
  • [3] Comparison of morbidity and mortality after bloodstream infection with vancomycin-resistant versus -susceptible Enterococcus faecium: a nationwide cohort study in Denmark, 2010-2019
    Bager, Peter
    Kaehler, Jonas
    Andersson, Mikael
    Holzknecht, Barbara Juliane
    Hansen, Sanne Gronvall Kjaer
    Schonning, Kristian
    Nielsen, Karen Leth
    Koch, Kristoffer
    Pinholt, Mette
    Voldstedlund, Marianne
    Larsen, Anders Rhod
    Kristensen, Brian
    Molbak, Kare
    Soenksen, Ute Wolff
    Skovgaard, Sissel
    Skov, Robert
    Hammerum, Anette M.
    EMERGING MICROBES & INFECTIONS, 2024, 13 (01)
  • [4] Predictors of mortality and poor outcome in cancer patients with E. faecium bloodstream infection
    Perez-Garcia, A.
    Beunza, J. J.
    Gea, A.
    Landecho, M. F.
    Mauleon, E.
    del Pozo, J. L.
    ANALES DEL SISTEMA SANITARIO DE NAVARRA, 2015, 38 (01) : 71 - 77
  • [5] Risk factors for mortality after linezolid treatment of Enterococcus bloodstream infection
    Huang, Szu-Ting
    Yang, Jia-Ling
    Lin, Chi-Ying
    Hang, Sung-Hsi
    Wang, Jann-Tay
    Chuang, Yu-Chung
    Chen, Yee-Chun
    Chang, Shan-Chwen
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2023, 129 : 96 - 102
  • [6] The ongoing challenge of vancomycin-resistant Enterococcus faecium and Enterococcus faecalis in Europe: an epidemiological analysis of bloodstream infections
    Ayobami, Olaniyi
    Willrich, Niklas
    Reuss, Annicka
    Eckmanns, Tim
    Markwart, Robby
    EMERGING MICROBES & INFECTIONS, 2020, 9 (01) : 1180 - 1193
  • [7] Comparison of Health Care-Associated Enterococcus faecium and Enterococcus faecalis Bloodstream Infections
    Alkan-Ceviker, Sevil
    Gunal, Ozgur
    Koksal, Eda
    Aygun, Cemanur
    Kilic, Suleyman Sirri
    KLIMIK JOURNAL, 2020, 33 (01) : 87 - 90
  • [8] Algorithm for pre-emptive glycopeptide treatment in patients with haematologic malignancies and an Enterococcus faecium bloodstream infection
    Zhou, Xuewei
    Arends, Jan P.
    Span, Lambert F. R.
    Friedrich, Alexander W.
    ANTIMICROBIAL RESISTANCE AND INFECTION CONTROL, 2013, 2
  • [9] Evaluation of early clinical failure criteria in Enterococcus species bloodstream infection
    Powers, Caroline E.
    Bookstaver, P. Brandon
    Caulder, Celeste
    Bouknight, Abigail
    Justo, Julie Ann
    Kohn, Joseph
    Winders, Hana Rac
    Al-Hasan, Majdi N.
    INFECTION, 2022, 50 (04) : 873 - 877
  • [10] Comprehensive Comparative Analysis of Enterococcus faecalis versus Enterococcus faecium Strains Isolated from Clinical Samples: A Retrospective Observational Study
    Bulut, Dilek
    Karakoc Parlayan, Hanife Nur
    Sencan, Irfan
    FLORA INFEKSIYON HASTALIKLARI VE KLINIK MIKROBIYOLOJI DERGISI, 2024, 29 (02): : 280 - 288